Avantor, Inc. Amortization of Debt Issuance Costs
Avantor, Inc. (AVTR) reported Amortization of Debt Issuance Costs of $1.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-04-29
- Avantor, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $1.80M, a 18.18% decline year-over-year.
- Avantor, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $1.90M, a 26.92% decline year-over-year.
- Avantor, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $2.10M, a 25.00% decline year-over-year.
- Avantor, Inc. amortization of debt issuance costs for the quarter ending 2025-06-30 was $2.30M, a 17.86% decline year-over-year.
- Avantor, Inc. amortization of debt issuance costs for fiscal 2025 was $8.50M, a 24.11% decline from fiscal 2024.
- Avantor, Inc. amortization of debt issuance costs for fiscal 2024 was $11.20M, a 13.85% decline from fiscal 2023.
- Avantor, Inc. amortization of debt issuance costs for fiscal 2023 was $13.00M, a 17.20% decline from fiscal 2022.
- Avantor, Inc. amortization of debt issuance costs for fiscal 2022 was $15.70M, a 3.68% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 1 month | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $1.80M 10-Q · filed 2026-04-29 | $3.70M derived: sum of 2 quarters · filed 2026-04-29 | $5.80M derived: sum of 3 quarters · filed 2026-04-29 | $8.10M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.00M derived: sum of 2 quarters · filed 2026-02-11 | $6.30M derived: sum of 3 quarters · filed 2026-02-11 | $8.50M 10-K · filed 2026-02-11 | |
| 2025-10-31 | $4.40M 10-Q · filed 2026-04-29 | ||||
| 2025-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $4.40M derived: sum of 2 quarters · filed 2025-10-29 | $6.60M 10-Q · filed 2025-10-29 | $9.20M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $4.50M 10-Q · filed 2025-08-01 | $7.10M derived: sum of 3 quarters · filed 2026-04-29 | $9.90M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2025-03-31 | $2.20M 10-Q · filed 2026-04-29 | $4.80M derived: sum of 2 quarters · filed 2026-04-29 | $7.60M derived: sum of 3 quarters · filed 2026-04-29 | $10.40M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $5.40M derived: sum of 2 quarters · filed 2026-02-11 | $8.20M derived: sum of 3 quarters · filed 2026-02-11 | $11.20M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $5.60M derived: sum of 2 quarters · filed 2025-10-29 | $8.60M 10-Q · filed 2025-10-29 | $11.70M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $5.80M 10-Q · filed 2025-08-01 | $8.90M derived: sum of 3 quarters · filed 2026-02-11 | $12.10M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | $3.00M 10-Q · filed 2025-04-25 | $6.10M derived: sum of 2 quarters · filed 2026-02-11 | $9.30M derived: sum of 3 quarters · filed 2026-02-11 | $12.60M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $6.30M derived: sum of 2 quarters · filed 2026-02-11 | $9.60M derived: sum of 3 quarters · filed 2026-02-11 | $13.00M 10-K · filed 2026-02-11 | |
| 2023-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $6.50M derived: sum of 2 quarters · filed 2024-10-25 | $9.90M 10-Q · filed 2024-10-25 | $13.50M derived: sum of 4 quarters · filed 2025-02-07 | |
| 2023-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $6.70M 10-Q · filed 2024-07-26 | $10.30M derived: sum of 3 quarters · filed 2025-02-07 | $13.90M derived: sum of 4 quarters · filed 2025-02-07 | |
| 2023-03-31 | $3.40M 10-Q · filed 2024-04-26 | $7.00M derived: sum of 2 quarters · filed 2025-02-07 | $10.60M derived: sum of 3 quarters · filed 2025-02-07 | $14.70M derived: sum of 4 quarters · filed 2025-02-07 | |
| 2022-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $7.20M derived: sum of 2 quarters · filed 2025-02-07 | $11.30M derived: sum of 3 quarters · filed 2025-02-07 | $15.70M 10-K · filed 2025-02-07 | |
| 2022-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $7.70M derived: sum of 2 quarters · filed 2023-10-27 | $12.10M 10-Q · filed 2023-10-27 | $16.70M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $8.50M 10-Q · filed 2023-07-28 | $13.10M derived: sum of 3 quarters · filed 2024-02-14 | $17.20M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | $4.40M 10-Q · filed 2023-04-28 | $9.00M derived: sum of 2 quarters · filed 2024-02-14 | $13.10M derived: sum of 3 quarters · filed 2024-02-14 | $16.80M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $8.70M derived: sum of 2 quarters · filed 2024-02-14 | $12.40M derived: sum of 3 quarters · filed 2024-02-14 | $16.30M 10-K · filed 2024-02-14 | |
| 2021-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $7.80M derived: sum of 2 quarters · filed 2022-10-28 | $11.70M 10-Q · filed 2022-10-28 | $16.10M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $7.60M 10-Q · filed 2022-07-29 | $12.00M derived: sum of 3 quarters · filed 2023-02-14 | $17.90M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | $3.90M 10-Q · filed 2022-04-29 | $8.30M derived: sum of 2 quarters · filed 2023-02-14 | $14.20M derived: sum of 3 quarters · filed 2023-02-14 | $20.40M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $10.30M derived: sum of 2 quarters · filed 2023-02-14 | $16.50M derived: sum of 3 quarters · filed 2023-02-14 | $23.40M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $12.10M derived: sum of 2 quarters · filed 2021-10-29 | $19.00M 10-Q · filed 2021-10-29 | $26.00M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-06-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $13.10M 10-Q · filed 2021-07-30 | $20.10M derived: sum of 3 quarters · filed 2022-02-11 | $27.30M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-03-31 | $6.90M 10-Q · filed 2021-04-28 | $13.90M derived: sum of 2 quarters · filed 2022-02-11 | $21.10M derived: sum of 3 quarters · filed 2022-02-11 | $30.00M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2019-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $14.20M derived: sum of 2 quarters · filed 2022-02-11 | $23.10M derived: sum of 3 quarters · filed 2022-02-11 | $33.50M 10-K · filed 2022-02-11 | |
| 2019-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $16.10M derived: sum of 2 quarters · filed 2020-10-27 | $26.50M 10-Q · filed 2020-10-27 | $36.80M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $19.30M 10-Q · filed 2020-07-29 | $29.60M derived: sum of 3 quarters · filed 2021-02-16 | $40.00M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-03-31 | $10.40M 10-Q · filed 2020-04-29 | $20.70M derived: sum of 2 quarters · filed 2021-02-16 | $31.10M derived: sum of 3 quarters · filed 2021-02-16 | ||
| 2018-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $20.70M derived: sum of 2 quarters · filed 2021-02-16 | $41.40M 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $31.10M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | $20.70M 10-Q · filed 2019-08-06 | ||||
| 2017-12-31 | $11.70M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |